Evidence map›Paper›PMID 31174585›Full record

ArticleOrphanet journal of rare diseases2019

"Be an ambassador for change that you would like to see": a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease.

Anna Ambrosini, Ros Quinlivan, Valeria A Sansone, Ingeborg Meijer, Guus Schrijvers, Aad Tibben, George Padberg, Maarten de Wit, Ellen Sterrenburg, Alexandre Mejat and 5 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Patient reported outcome measures in spinal muscular atrophy and duchenne muscular dystrophy: review of instruments and their inclusion in clinical and regulatory processes.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  3. Article
  4. Article
  5. Congenital Athymia: Unmet Needs and Practical Guidance.Therapeutics and clinical risk management · 2023
    Review
  6. Article
  7. Increasing Engagement of Women Veterans in Health Research.Journal of general internal medicine · 2022
    Article
  8. Neuromuscular disorders and transition from pediatric to adult care in a multidisciplinary perspective: a narrative review of the scientific evidence and current debate.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2022
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anna AmbrosiniFondazione Telethon, Via Poerio 14, 20129, Milan, Italy. aambrosini@telethon.it.ORCID 0000-0002-3065-975X
Ros QuinlivanMRC Centre for Neuromuscular Diseases, Institute of Neurology, Queen Square, London, UK.
Valeria A SansoneNEuroMuscular Omnicentre (NEMO), Neurorehabilitation Unit, University of Milan, ASST Grande Ospedale Metropolitano Niguarda, Fondazione Serena Onlus, Milan, Italy.
Ingeborg MeijerCentre for Science and Technology Studies (CWTS), University of Leiden, Leiden, The Netherlands.
Guus SchrijversSpierziekten Nederland, Baarn, the Netherlands.
Aad TibbenCentre for Human and Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
George PadbergCentre for Human and Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Maarten de WitDepartment of Medical Humanities, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Ellen SterrenburgPrinses Beatrix Spierfonds, The Hague, The Netherlands.
Alexandre MejatUniversity of Lyon, University of Lyon1 Claude Bernard Lyon1, Institut NeuroMyoGene, CNRS UMR5310, INSERM U1217, Lyon, France.
Alexandra BreukelEuropean Neuromuscular Centre, Baarn, The Netherlands.
Michal RatajPolish Neuromuscular Diseases Association (PTCHNM), Warszawa, Poland.
Hanns LochmüllerChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
Raffaella WillmannSwiss Foundation for Research on Muscle Diseases, Cortaillod, Switzerland.
235th ENMC workshop study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient and public involvement for co-creation is increasingly recognized as a valuable strategy to develop healthcare research targeting patients' real needs. However, its practical implementation is not as advanced and unanimously accepted as it could be, due to cultural differences and complexities of managing healthcare programs and clinical studies, especially in the rare disease field. MAIN BODY: The European Neuromuscular Centre, a European foundation of patient organizations, involved its key stakeholders in a special workshop to investigate the position of the neuromuscular patient community with respect to healthcare and medical research to identify and address gaps and bottlenecks. The workshop took place in Milan (Italy) on January 19-20, 2018, involving 45 participants who were mainly representatives of the patient community, but also included experts from clinical centers, industry and regulatory bodies. In order to provide practical examples and constructive suggestions, specific topics were identified upfront. The first set of issues concerned the quality of life at specific phases of a patient's life, such as at the time of diagnosis or during pediatric to adult transition, and patient involvement in medical research on activities in daily living including patient reported outcome measures. The second set of issues concerned the involvement of patients in the management of clinical research tools, such as registries and biobanks, and their participation in study design or marketing authorization processes. Introductory presentations were followed by parallel working group sessions, to gain constructive contributions from all participants. The concept of shared decision making was used to ensure, in discussions, a partnership-based identification of the wishes and needs of all stakeholders involved, and the "ladder of participation" tool served as a model to evaluate the actual and the desired level of patients' involvement in all topics addressed. A general consensus on the outcome of the meeting was collected during the final plenary session. This paper reports the outcome of the workshop and the specific suggestions derived from the analysis of the first set of topics, related to quality of life. The outcomes of the second set of topics are reported elsewhere and are only briefly summarized herein for the sake of completeness.

conclusionsThe neuromuscular community proved to be very active and engaged at different levels in the healthcare initiatives of interest. The workshop participants critically discussed several topics, providing practical examples where different stakeholders could play a role in making a change and bridging gaps. Overall, they indicated the need for education of all stakeholders for better communication, where everyone should become an ambassador to promote real change. Support should also come from institutions and healthcare bodies both at structural and economic level.

Indexed as

Decision MakingQuality of LifeBiomedical ResearchHumansNeuromuscular DiseasesCo-creationHealthcareNeuromuscular diseasesPatient engagementPatient involvement

Identifiers

PMID31174585
PMCPMC6555994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.